Drug Type Oligonucleotide |
Synonyms |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization SoVarGen Co., Ltd.Startup |
Active Organization SoVarGen Co., Ltd.Startup |
Inactive Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Brain Cancer | Discovery | KR | SoVarGen Co., Ltd.Startup | 08 Sep 2022 |